/
LFMD
$4.20+$0.07 (+1.57%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$199.7M
48M shares
52-week range
$2.56 – $14.43
14% from low
Sector
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Exchange
NASDAQ
CS
Borrow rate
0.38%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-7.58
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.3M | $12.5M | $37.3M | $92.9M | $119.0M | $152.5M | $212.5M | $194.1M |
| Cost of revenue | $2.0M | $2.5M | $8.9M | $18.0M | $18.7M | $18.9M | $24.1M | $39.3M |
| Gross profit | $6.4M | $9.9M | $28.4M | $74.9M | $100.4M | $133.6M | $188.4M | $154.8M |
| Gross margin | 76.3% | 79.7% | 76.2% | 80.6% | 84.3% | 87.6% | 88.7% | 79.8% |
| R&D | $120.5K | $222.9K | $446.7K | $948.2K | $3.0M | $6.1M | $9.5M | $7.3M |
| Operating income | −$2.1M | −$2.9M | −$57.8M | −$54.3M | −$43.4M | −$14.5M | −$16.1M | −$7.7M |
| EBITDA | −$1.9M | −$2.6M | −$57.5M | −$57.9M | −$38.6M | −$8.2M | −$6.7M | −$1.5M |
| Net income | −$1.2M | −$3.1M | −$58.6M | −$60.9M | −$45.5M | −$20.6M | −$18.9M | −$7.1M |
| Net margin | -14.9% | -25.2% | -157.3% | -65.6% | -38.3% | -13.5% | -8.9% | -3.7% |
| EPS (diluted) | -0.14 | -0.36 | -4.24 | -2.27 | -1.57 | -0.70 | -0.53 | -0.23 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $222M | $-0.27 | $-0.35–$-0.19 | 3 |
| 2027 | $261M | $0.07 | $-0.00–$0.15 | 3 |
| 2028 | $303M | $0.31 | $0.22–$0.36 | 3 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
LifeMD, Inc. Common Stock
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
www.lifemd.com- Employees
- 384
- IPO / List date
- Feb 1, 1995
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds LFMD.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,118,325 | $4.0M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded LFMD yet.
